To confirm that IL-6 enhancement of ovarian cancer cell migration depends on glucose metabolism, we performed a wound healing scratch assay in the presence of 2-deoxy-D-glucose (2-DG) or sodium oxamate, which inhibit upstream and downstream the glycolytic pathway, respectively. This evidence concerns the gene IL6 and ovarian carcinoma.